Page 133 - LIBRO DE PSICOFARMACOLOGÍA
P. 133
Capítulo 6: Ansiolíticos
BIBLIOGRAFÍAS
Ayuso JL. Trastornos de angustia. R Bayés y J Toro, eds. Martínez Roca SAo Barcelona
1988; 192 pp.
Ballenger JC y cols. Alprazolam in panic disorder and agoraphobia: Results from a
multicenter tria! 1. Efficacy in short-term treatment. ArchGen Psychiatry 1988; 45:
413-422.
Brodgen RN y cols. Flumazenil: A preliminary review of its benzodiazepine antagonist
properties, intrinsic activity and therapeutic use. Drugs 1988; 35: 448-467.
Casacchia M. A double-blind, placebo-controlled study of alpidem, a novel anxiolytic of
imidazopyridine structure, in chronically anxious patients. Acta Psychiatr Scand
1989; 80: 137-141.
Casacchia M. Therapeutic activity of alpidem in anxious patients: Anoverview of European
studies. En: Biological Psychiatry. G Racagni, N Brunello y T Fukuda, eds. Excerpta
Médica. Amsterdam 1991; vol I: pp 689-690.
Conde López V, Martínez Roig M. Algunos aspectos farmacológicos clínicos de las
azaspirodecanodionas. Farmacología del SNC 1990; 4:85-102.
Fármacos ansiolíticos y sedantes. En: Farmacología Humana.J Flórez, JA Armijo y A
Mediavilla, eds. EUNSA. Pamplona 1987; Tomo I: pp 301-315.
Gaillard JM. Rational approach to the treatment to insomnia. En: Biological Psychiatry. G
Racagni, N Brunello y T Fukuda, eds. Excerpta Medica. Amsterdam 1991; vol I: pp
854-855.
Goa KL y cols. Zopiclone: A review of its pharmacodynamic and pharmacokinetic properties
and therapeutic efficacy as a hypnotic. Drugs 1986; 32: 48-65.
131

